"Burke Primary Care is a comprehensive family practice dedicated to high quality, patient-focused healthcare. Treating patients from birth to seniors (geriatric) in wellness and acute illness care, Burke Primary Care is a locally owned, independent family physician medical practice. Conveniently located adjacent to Blue Ridge Hospital (off East Parker Road) in Morganton, NC, Burke Primary Care offers extended hours: 8am to 8pm, Monday - Friday and from 8 am to noon on Saturdays to meet the healthcare needs of busy families and working adults."

During the past decade, Burke Primary Care conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Burke Primary Care" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Purdue Pharma LP" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "60 Degrees Pharmaceuticals LLC" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Burke Primary Care" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Burke Primary Care" are "Cardiovascular Disease" (3 trials), "Type 2 Diabetes" (3 trials), "Back Pain Lower Back Chronic" (2 trials), "Gout" (2 trials) and "Respiratory Syncytial Virus" (2 trials). Many other conditions were trialed in "Burke Primary Care" in a lesser frequency.

Most popular intervention types in "Burke Primary Care" are "Drug" (21 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Dapagliflozin" (2 trials), "Naproxen" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "ALLN-346" (1 trials). Other intervention names were less common.

The vast majority of trials in "Burke Primary Care" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Burke Primary Care". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Burke Primary Care, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Burke Primary Care, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".